Article Details

Good Therapeutics Announces Acquisition of Conditionally Active PD-1-regulated IL-2 ... - Benzinga

Retrieved on: 2022-09-07 11:13:13

Tags for this article:

Click the tags to see associated articles and topics

Good Therapeutics Announces Acquisition of Conditionally Active PD-1-regulated IL-2 ... - Benzinga. View article details on hiswai:

Excerpt

Under the terms of the merger agreement, Roche will make an upfront cash payment of $250 million for the shares on a fully diluted basis and ...

Article found on: www.benzinga.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up